Verapamil Hydrochloride Tablet
Product Images NDC 51655-734

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 51655-734). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 734 52 Master Bottle Label Approval Rev A 06 21)

Label (51655 734 52 Master Bottle Label Approval   Rev A 06 21)
Label for Verapamil Hydrochloride Extended-Release Tablets, USP 180 mg, oral tablet dosage form. Contains 30 tablets per package. Labeler is Northwind Health Company, LLC. Includes storage instructions and dosage note to see package insert. NDC is 51655-734.*
FDA Label Image

Chemical Structure (Verapamil 01)

Chemical Structure (Verapamil 01)
Chemical structure of verapamil hydrochloride, showing its molecular arrangement including methoxyphenyl groups and associated hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.